Aimedis
PrivateLast Round
Token Sale
Nov 25, 2021
Est. Valuation
$30M
Total Funding Raised
$1.1M
Company Overview
Aimedis operates in Healthcare & Life Sciences and is based in the Netherlands. Its latest recorded funding round was a Token Sale round in November 2021.
Aimedis is a healthtech company that provides a blockchain-based platform for medical records, telemedicine, and a healthcare-focused metaverse.
Sector
Healthcare & Life Sciences
Verticals
EHR & EMR, Telemedicine, Blockchain Infrastructure, Healthcare Analytics, Tokenization
Business Model
B2B
Customer Profile
Data as a Service, Freemium, Marketplace Commission
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Aimedis Comparables
Compare Aimedis with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Patientory Inc. | 78% | |
| MediBloc | 77% | |
| DeHealth | 74% |
For institutional investors. Book with your work email.
Aimedis Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Token Sale | Nov 25, 2021 | ||||
| Initial Coin Offering | Apr 1, 2018 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Nov 25, 2021
$300K raised from ProBit Global and Sekuritance.
- Apr 1, 2018
$1.1M raised in an ICO round.
For institutional investors. Book with your work email.
Aimedis Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Aimedis's valuation, stock price, and market status.
Is Aimedis a public or private company?
Aimedis is a private company.
What is the current stock price of Aimedis?
Aimedis is a private company, so its shares have no public market price. Caplight tracks Aimedis's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Aimedis worth (valuation)?
Aimedis's valuation is estimated at $30.0M based on funding round data.
Can I buy Aimedis stock?
Aimedis shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Aimedis's last funding round?
Aimedis's most recent funding round was Token Sale on November 25, 2021.
Who are the main investors in Aimedis?
Investor information for Aimedis is not publicly disclosed.
Will Aimedis IPO soon?
No public IPO plans have been announced for Aimedis.
How can I track Aimedis secondary market activity?
Caplight tracks bids, offers, and trades in Aimedis's shares on secondary markets.